Astellas Pharma | 4503 - Net Income

Stock Price
2,150.50
Daily Change
6.50 0.30%
Monthly
0.96%
Yearly
46.14%
Q1 Forecast
2,057.60

Astellas Pharma reported JPY79.21B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Astellas Pharma JPY 79.21B 10.79B Sep/2025
Chugai Pharma JPY 128.41B 17.2B Dec/2025
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Eisai JPY 10.16B 4.32B Sep/2025
Kyowa Hakko Kirin JPY 16.28B 6.13B Sep/2025
M3 JPY 10.87B 969M Sep/2025
Otsuka Holdings JPY 124.13B 35.6B Sep/2025
Shionogi JPY 74.68B 30.5B Dec/2025
Sumitomo Dainippon JPY 87.65B 76.45B Sep/2025
Takeda JPY 103.64B 115.44B Dec/2025
Terumo JPY 35.05B 6.79B Sep/2025